Form 8-K - Current report:
SEC Accession No. 0001171843-25-005815
Filing Date
2025-09-10
Accepted
2025-09-10 09:00:46
Documents
15
Period of Report
2025-09-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_091025.htm   iXBRL 8-K 20391
2 EXHIBIT 99.1 exh_991.htm EX-99.1 238989
6 GRAPHIC sign.jpg GRAPHIC 10369
7 GRAPHIC sign1.jpg GRAPHIC 10207
  Complete submission text file 0001171843-25-005815.txt   499690

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abus-20250909.xsd EX-101.SCH 3020
4 XBRL LABEL FILE abus-20250909_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE abus-20250909_pre.xml EX-101.PRE 22362
17 EXTRACTED XBRL INSTANCE DOCUMENT f8k_091025_htm.xml XML 3565
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 251304777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)